Italian Multicenter Retrospective Observational Study on Transformed Lymphomas

A.O.U. Città della Salute e della Scienza180 enrolled

Overview

Study purpose is to evaluate treatment outcome and survival in patient with aggressive lymphomas transformed from Follicular Lymphoma.

Study Type

OBSERVATIONAL

Enrollment

180

Conditions

Non-Hodgkin Lymphoma Transformed Recurrent

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Histologically confirmed transformed Follicular Lymphoma * Age \> 18 years * Histological transformation between January 2002 and December 2014 * Availability of data about treatment and outcome Exclusion Criteria: * Other lymphoma diagnosis

Locations (1)

SC Ematologia - AOU Città della Salute e della Scienza di Torino

Torino, Italy

RECRUITING

Outcomes

Primary Outcomes

Progression Free Survival

Time from last response to nearest relapse or follow-up

Time frame: From first response to last follow-up for at least 2 years (up to 15 years)

Overall Survival

Time to last follow-up or death

Time frame: Date of last follow-up for at least 2 years (up to 15 years)

Central Contacts

Barbara Botto, MD

CONTACT

+390116334553 bbotto@cittadellasalute.to.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.